Premier Clinical Research Institute Inc

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study	Hallucinations, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, perceptual disorders	Enrolling by invitation	Phase 3	2026-08-05		NCT06194799
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 2	2026-07-27		NCT07115329

Clinical trials